Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exelixis Inc
(NQ:
EXEL
)
20.78
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exelixis Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
May 20, 2023
Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.
Via
The Motley Fool
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
May 18, 2023
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
Via
MarketBeat
Exposures
Product Safety
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip
May 13, 2023
A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals.
Via
The Motley Fool
8 Analysts Have This to Say About Exelixis
May 10, 2023
Via
Benzinga
Exelixis (EXEL) Q1 2023 Earnings Call Transcript
May 10, 2023
EXEL earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Exelixis: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
What 9 Analyst Ratings Have To Say About Exelixis
April 12, 2023
Via
Benzinga
Why Exelixis Stock Leaped More Than 4% Higher Today
March 20, 2023
Oh, how some investors love stock buyback programs.
Via
The Motley Fool
Analyst Ratings for Exelixis
March 20, 2023
Via
Benzinga
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Exelixis, Inc.
Via
Business Wire
Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns
May 08, 2023
Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board,
Via
Benzinga
Farallon Capital Management Comments on Successful Campaign for Change at Exelixis
May 07, 2023
From
Farallon Capital Management L.L.C.
Via
Business Wire
Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors
May 07, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023
May 03, 2023
From
Exelixis, Inc.
Via
Business Wire
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates
May 03, 2023
From
Farallon Capital Management L.L.C.
Via
Business Wire
Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
May 01, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 25, 2023
From
Exelixis, Inc.
Via
Business Wire
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
April 22, 2023
These cheap stocks have the potential to skyrocket over the long haul.
Via
The Motley Fool
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip
April 22, 2023
Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite.
Via
The Motley Fool
Exelixis Advances Board Refreshment Plan
April 13, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis Reiterates Commitment to Shareholder Value Creation
April 05, 2023
From
Exelixis, Inc.
Via
Business Wire
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
Both companies have game-changing product portfolios that should result in stock price growth.
Via
The Motley Fool
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories
April 05, 2023
Benzinga
Via
Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
April 05, 2023
Via
Benzinga
Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change
April 05, 2023
From
Farallon Capital Management L.L.C.
Via
Business Wire
2 Incredible Stocks to Buy With Less Than $25
April 04, 2023
Nothing beats a great investment for the price of just a few cups of coffee.
Via
The Motley Fool
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
March 27, 2023
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier.
Via
Investor's Business Daily
Exelixis Announces $550 Million Share Repurchase Program
March 20, 2023
From
Exelixis, Inc.
Via
Business Wire
3 Beaten-Down Stocks That Could Soar This Year
March 18, 2023
These stocks could enjoy big rebounds in 2023.
Via
The Motley Fool
Exelixis Stock Generating Improved Relative Strength Rating
March 16, 2023
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.